TARS SG&A Expense Growth
Tarsus Pharmaceuticals Inc · SG&A Expense Growth
TARS SG&A Expense Growth
Latest reported80.07%period ending
TARS FY SG&A Growth (YoY) (0.00% → 80.07%)
Latest values, visible window
High-resolution chart · PNG
TARS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 80.0695% | |
| 118.3165% | |
| 141.8296% | |
| 76.9855% | |
| 220.4264% | |
| 646.3277% | |
| 137.0536% | |
| 0% |